Corrigendum to "Advances in Trop2-targeted therapy: Novel agents and opportunities beyond breast cancer" [Pharmacology & Therapeutics 239 (2022) 108296]
Pharmacol Ther. 2023 Mar:243:108336.
doi: 10.1016/j.pharmthera.2022.108336.
Epub 2023 Feb 15.
1 Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China.
2 Shanghai Asia United Antibody Medical Co., Ltd, Shanghai 201203, China.
3 Aerospace Information Research Institute, Chinese Academy of Sciences, Beijing 100094, China.
4 School of Social Science, The University of Manchester, Manchester, UK.
5 Cancer Institute, The Affiliated Hospital of Qingdao University, Qingdao University, Qingdao Cancer Institute, Qingdao 266071, China; School of Life Sciences, Tsinghua University, Beijing 100084, China. Electronic address: xdm_tsinghua@163.com.